IBB ETF top 10 holdings are 44.9% of the fund as of Jun 30, 2026
IBB ETF top 10 holdings are 44.9% of the fund as of Jun 30, 2026
$213.56
AUM$10.0B
TER0.44%
Holdings253
See how much of IBB you already own
IBB ETF top 10 holdings are 44.9% of the fund as of Jun 30, 2026
$213.56
iShares Biotechnology ETF
AUM$10.0B
TER0.44%
Holdings253
See how much of IBB you already own
IBB holds 44.9% of its assets in its 10 largest positions as of Jun 30, 2026. IBB is iShares Biotechnology ETF.
IBB ETF Top Holdings
IBB holdings top 10 positions. The top 10 holdings account for 44.9% of the fund, led by Nvaesrtex Pharmaceuticals Inc at 8.4%, Amgen Inc. at 7.7%, Gilead Sciences at 6.8%.
IBB portfolio concentration is moderate, with the top 10 representing 44.9% of total assets. The largest sector exposure is Health Care at 93.8%.
IBB sectors provide a detailed breakdown. IBB overlap shows how holdings compare to other funds in your portfolio.






